GFAP and neoplasm: We found a significant decrease in GFAP (Fig. 3h, i) and CSPGs (Fig. 3j, k) expression in the tumor periphery region, which did not overlap with the GBM region (GFP-labeled U87 MG), of KDS2010-treated mice.